注射用头孢哌酮钠舒巴坦钠与注射用盐酸川芎嗪存在配伍禁忌

摘要

目的为防止未知药物间发生配伍禁忌，避免不必要的医疗纠纷。方法将1瓶注射用头孢哌酮钠舒巴坦钠注于0.9%氯化钠液中，呈无色透明溶液。将1瓶注射用川芎嗪溶于5%葡萄糖溶液中，呈无色透明溶液。用5 ml空针抽吸1 ml注射用头孢哌酮钠舒巴坦钠溶液和1 ml注射用盐酸川芎嗪注射液溶液混合，立即出现白色絮状物。结果规范后，发生药物不良反应的患者较前有所下降。结论规范用药的配伍禁忌，可提高护士的风险防范意识，指导和规范护士对药物间发生化学反应的处理方法，减少纠纷和投诉，既保证了患者的权益，也保护了护士的利益。%Objective In order to prevent the incompatibility between the unknown drug, avoid unnecessary disputes.Methods 1 bot les of Cefoperazone Sodium and Sulbactam Sodium for Injection injection in 0.9%sodium chloride solution, a colorless and transparent solution. The 1 bot le injection with Ligustrazine dissolved in 5%glucose solution, a colorless and transparent solution. Use 5ml empty needle aspiration 1ml Cefoperazone Sodium and Sulbactam Sodium for Injection solution and 1ml injection of ligustrazine hydrochloride injection with mixed solution, immediately appear white floc.Results Standard, the occur ence of adverse drug reactions in patients with a decreased.Conclusion Incompatibility of standard medication, can improve nurses' consciousness of risk prevention, guide and standardize the nurse to disposal methods of chemical reaction occurs between drugs, reduce disputes and complaints, both to ensure the rights of patients, but also to protect the interests of nurses.